SMAD3 and renal fibrosis: In this case, eNOS could phosphorylate VEGF and vice-versa, protecting podocyte loss, glomerular and peritubular vascular rarefaction, renal fibrosis [50], and inhibiting the expression of TGFβ-Smad3 [51].